NCT04363801 2025-10-09
DisTinGuish
Leap Therapeutics, Inc.
Phase 2 Terminated
Leap Therapeutics, Inc.
University of Campinas, Brazil
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
Stanford University